The diagnostic challenge of patients with anti-U1-RNP antibodies

Sharp GC, Irvin WS, Tan EM, Gould RG, Holman HR (1972) Mixed connective tissue disease-an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med 52:148–159. https://doi.org/10.1016/0002-9343(72)90064-2 Greidinger EL, Hoffman RW (2005) Autoantibodies in the pathogenesis of mixed connective tissue disease. Rheum Dis Clin N Am 31:437–450. https://doi.org/10.1016/j.rdc.2005.04.004 Cervera R, Khamashta MA, Hughes GRV (2009) The Euro-lupus project: epidemiology of systemic lupus erythematosus in Europe. Lupus 18:869–874. https://doi.org/10.1177/0961203309106831 Dima A, Jurcut C, Baicus C (2018) The impact of anti-U1-RNP positivity: systemic lupus erythematosus versus mixed connective tissue disease. Rheumatol Int 38:1169–1178. https://doi.org/10.1007/s00296-018-4059-4 Abbara S, Seror R, Henry J, Chretien P, Gleizes A, Hacein-Bey-Abina S, Mariette X, Nocturne G (2019) Anti-RNP positivity in primary Sjögren’s syndrome is associated with a more active disease and a more frequent muscular and pulmonary involvement. RMD Open 5:e001033. https://doi.org/10.1136/rmdopen-2019-001033 Li X, Liu X, Cui J, Song W, Liang Y, Hu Y, Guo Y (2019) Epidemiological survey of antinuclear antibodies in healthy population and analysis of clinical characteristics of positive population. J Clin Lab Anal 33:e22965. https://doi.org/10.1002/jcla.22965 Alarcón-Segovia VMD (1987) Classification and diagnostic criteria for mixed connective tissue disease. pp 33–40 Kasukawa TTR (1987) Preliminary diagnostic criteria for classification of mixed connective tissue disease. Mix connect tissue dis anti-nucl antibodies. Elsevier Science Publishers B.V (Biomedical Division), Amsterdam, pp 41–47 Cappelli S, Randone SB, Martinovic D, Tamas MM, Pasalic K, Allanore Y, Mosca M, Talarico R, Opris D, Kiss CG, Tausche AK, Cardarelli S, Riccieri V, Koneva O, Cuomo G, Becker MO, Sulli A, Guiducci S, Radic M, Bombardieri S, Aringer M, Cozzi F, Valesini G, Ananyeva L, Valentini G, Riemekasten G, Cutolo M, Ionescu R, Czirják L, Damjanov N, Rednic S, Cerinic MM (2012) “To be or not to be”, ten years after evidence for mixed connective tissue disease as a distinct entity. Semin Arthritis Rheum. https://doi.org/10.1016/j.semarthrit.2011.07.010 John KJ, Sadiq M, George T, Gunasekaran K, Francis N, Rajadurai E, Sudarsanam TD (2020) Clinical and immunological profile of mixed connective tissue disease and a comparison of four diagnostic criteria. Int J Rheumatol 2020:9692030. https://doi.org/10.1155/2020/9692030 Gendi NS, Welsh KI, Van Venrooij WJ, Vancheeswaran R, Gilroy J, Black CM (1995) HLA type as a predictor of mixed connective tissue disease differentiation. Ten-year clinical and immunogenetic followup of 46 patients. Arthritis Rheum 38:259–266. https://doi.org/10.1002/art.1780380216 De Clerck LS, Meijers KA, Cats A (1989) Is MCTD a distinct entity? Comparison of clinical and laboratory findings in MCTD, SLE, PSS, and RA patients. Clin Rheumatol 8:29–36. https://doi.org/10.1007/BF02031065 LeRoy EC, Maricq HR, Kahaleh MB (1980) Undifferentiated connective tissue syndromes. Arthritis Rheum 23:341–343. https://doi.org/10.1002/art.1780230312 Nishioka R, Zoshima T, Hara S, Suzuki Y, Ito K, Yamada K, Nakashima A, Tani Y, Kawane T, Hirata M, Mizushima I, Kawano M (2021) Urinary abnormality in mixed connective tissue disease predicts development of other connective tissue diseases and decrease in renal function. Mod Rheumatol. https://doi.org/10.1080/14397595.2021.1899602 Hetlevik SO, Flatø B, Rygg M, Nordal EB, Brunborg C, Hetland H, Lilleby V (2017) Long-term outcome in juvenile-onset mixed connective tissue disease: a nationwide Norwegian study. Ann Rheum Dis 76:159–165. https://doi.org/10.1136/annrheumdis-2016-209522 Frandsen PB, Kriegbaum NJ, Ullman S, Høier-Madsen M, Wiik A, Halberg P (1996) Follow-up of 151 patients with high-titer U1RNP antibodies. Clin Rheumatol 15:254–260. https://doi.org/10.1007/BF02229703 Alves MR, Isenberg DA (2020) “Mixed connective tissue disease”: a condition in search of an identity. Clin Exp Med 20:159–166. https://doi.org/10.1007/s10238-020-00606-7 Swanton J, Isenberg D (2005) Mixed connective tissue disease: still crazy after all these years. Rheum Dis Clin N Am 31:421–436. https://doi.org/10.1016/j.rdc.2005.04.009 Carpintero M, Martinez L, Fernandez I, Romero AG, Mejia C, Zang Y, Hoffman R, Greidinger E (2015) Diagnosis and risk stratification in patients with anti-RNP autoimmunity. Lupus. https://doi.org/10.1177/0961203315575586 Reichlin M (1976) Problems in differentiating SLE and mixed connective-tissue disease. N Engl J Med 295:1194–1195. https://doi.org/10.1056/NEJM197611182952112 van den Hoogen FH, Spronk PE, Boerbooms AM, Bootsma H, de Rooij DJ, Kallenberg CG, van de Putte LB (1994) Long-term follow-up of 46 patients with anti-(U1)snRNP antibodies. Br J Rheumatol 33:1117–1120. https://doi.org/10.1093/rheumatology/33.12.1117 Migliorini P, Baldini C, Rocchi V, Bombardieri S (2005) Anti-Sm and anti-RNP antibodies. Autoimmunity 38:47–54. https://doi.org/10.1080/08916930400022715 Lemerle J, Renaudineau Y (2016) Anti-Sm and Anti-U1-RNP antibodies: an update. Lupus Open Access. 1:1–4. https://doi.org/10.35248/2684-1630.16.1.e104 Burdt MA, Hoffman RW, Deutscher SL, Wang GS, Johnson JC, Sharp GC (1999) Long-term outcome in mixed connective tissue disease: longitudinal clinical and serologic findings. Arthritis Rheum 42:899–909. https://doi.org/10.1002/1529-0131(199905)42:5%3c899::AID-ANR8%3e3.0.CO;2-L Aringer M, Steiner G, Smolen JS (2005) Does mixed connective tissue disease exist? Yes. Rheum Dis Clin N Am 31:411–420. https://doi.org/10.1016/j.rdc.2005.04.007 Tani C, Carli L, Vagnani S, Talarico R, Baldini C, Mosca M, Bombardieri S (2014) The diagnosis and classification of mixed connective tissue disease. J Autoimmun 48–49:46–49. https://doi.org/10.1016/j.jaut.2014.01.008 Ciang NCO, Pereira N, Isenberg DA (2017) Mixed connective tissue disease-enigma variations? Rheumatol Oxf Engl 56:326–333. https://doi.org/10.1093/rheumatology/kew265 Barsotti S, Orlandi M, Codullo V, Di Battista M, Lepri G, Della Rossa A, Guiducci S (2019) One year in review 2019: systemic sclerosis. Clin Exp Rheumatol 37(Suppl 119):3–14 Tanaka Y (2020) State-of-the-art treatment of systemic lupus erythematosus. Int J Rheum Dis 23:465–471. https://doi.org/10.1111/1756-185X.13817 Sparks JA (2019) Rheumatoid arthritis. Ann Intern Med 170:ITC1–ITC16. https://doi.org/10.7326/AITC201901010 Fanouriakis A, Kostopoulou M, Alunno A, Aringer M, Bajema I, Boletis JN, Cervera R, Doria A, Gordon C, Govoni M, Houssiau F, Jayne D, Kouloumas M, Kuhn A, Larsen JL, Lerstrøm K, Moroni G, Mosca M, Schneider M, Smolen JS, Svenungsson E, Tesar V, Tincani A, Troldborg A, van Vollenhoven R, Wenzel J, Bertsias G, Boumpas DT (2019) update of the EULAR recommendations for the management of systemic lupus erythematosus. Ann Rheum Dis 78(2019):736–745. https://doi.org/10.1136/annrheumdis-2019-215089 Didier K, Bolko L, Giusti D, Toquet S, Robbins A, Antonicelli F, Servettaz A (2018) Autoantibodies associated with connective tissue diseases: what meaning for clinicians? Front Immunol 9. https://www.frontiersin.org/article/https://doi.org/10.3389/fimmu.2018.00541 (accessed 6 Feb 2022 Anderson SG, Bentzon MW, Houba V, Krag P (1970) International reference preparation of rheumatoid arthritis serum. Bull World Health Organ 42:311–318 Sammaritano LR (2020) Antiphospholipid syndrome. Best Pract Res Clin Rheumatol 34:101463. https://doi.org/10.1016/j.berh.2019.101463 Petri M, Orbai A-M, Alarcón GS, Gordon C, Merrill JT, Fortin PR, Bruce IN, Isenberg D, Wallace DJ, Nived O, Sturfelt G, Ramsey-Goldman R, Bae S-C, Hanly JG, Sánchez-Guerrero J, Clarke A, Aranow C, Manzi S, Urowitz M, Gladman D, Kalunian K, Costner M, Werth VP, Zoma A, Bernatsky S, Ruiz-Irastorza G, Khamashta MA, Jacobsen S, Buyon JP, Maddison P, Dooley MA, van Vollenhoven RF, Ginzler E, Stoll T, Peschken C, Jorizzo JL, Callen JP, Lim SS, Fessler BJ, Inanc M, Kamen DL, Rahman A, Steinsson K, Franks AG, Sigler L, Hameed S, Fang H, Pham N, Brey R, Weisman MH, McGwin G, Magder LS (2012) Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 64:2677–2686. https://doi.org/10.1002/art.34473 Kay J, Upchurch KS (2012) ACR/EULAR 2010 rheumatoid arthritis classification criteria. Rheumatol Oxf Engl. 51(Suppl 6):5–9. https://doi.org/10.1093/rheumatology/kes279 Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM, Rasmussen A, Scofield H, Vitali C, Bowman SJ, Mariette X, International Sjögren’s Syndrome Criteria Working Group (2016) American College of Rheumatology/European League Against Rheumatism Classification Criteria for Primary Sjögren’s syndrome: a consensus and data-driven methodology involving three international patient cohorts. Arthritis Rheumatol Hoboken NJ. 69(2017):35–45. https://doi.org/10.1002/art.39859 Bajema IM, Wilhelmus S, Alpers CE, Bruijn JA, Colvin RB, Cook HT, D’Agati VD, Ferrario F, Haas M, Jennette JC, Joh K, Nast CC, Noël L-H, Rijnink EC, Roberts ISD, Seshan SV, Sethi S, Fogo AB (2018) Revision of the International Society of Nephrology/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices. Kidney Int 93:789–796. https://doi.org/10.1016/j.kint.2017.11.023 van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, Matucci-Cerinic M, Naden RP, Medsger TA, Carreira PE, Riemekasten G, Clements PJ, Denton CP, Distler O, Allanore Y, Furst DE, Gabrielli A, Mayes MD, van Laar JM, Seibold JR, Czirjak L, Steen VD, Inanc M, Kowal-Bielecka O, Müller-Ladner U, Valentini G, Veale DJ, Vonk MC, Walker UA, Chung L, Collier DH, Ellen Csuka M, Fessler BJ, Guiducci S, Herrick A, Hsu VM, Jimenez S, Kahaleh B, Merkel PA, Sierakowski S, Silver RM, Simms RW, Varga J, Pope JE (2013) classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. Ann Rheum Dis 72(2013):1747–1755. https://doi.org/10.1136/annrheumdis-2013-204424 Galiè N, Humbert M, Vachiery J-L, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, VonkNoordegraaf A, Beghetti M, Ghofrani A, Gomez Sanchez MA, Hansmann G, Klepetko W, Lancellotti P, Matucci M, McDonagh T, Pierard LA, Trindade PT, Zompatori M, Hoeper M, ESC Scientific Document Group (2016) 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: the joint task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J 37:67–119. https://doi.org/10.1093/eurheartj/ehv317 Kondoh Y, Makino S, Ogura T, Suda T, Tomioka H, Amano H, Anraku M, Enomoto N, Fujii T, Fujisawa T, Gono T, Harigai M, Ichiyasu H, Inoue Y, Johkoh T, Kameda H, Kataoka K, Katsumata Y, Kawaguchi Y, Kawakami A, Kitamura H, Kitamura N, Koga T, Kurasawa K, Nakamura Y, Nakashima R, Nishioka Y, Nishiyama O, Okamoto M, Sakai F, Sakamoto S, Sato S, Shimizu T, Takayanagi N, Takei R, Takemura T, Takeuchi T, Toyoda Y, Yamada H, Yamakawa H, Yamano Y, Yamasaki Y, Kuwana M, Joint committee of Japanese Respiratory Society and Japan College of Rheumatology (2021) 2020 guide for the diagnosis and treatment of interstitial lung disease associated with connective tissue disease. Respir Investig 59:709–740. https://doi.org/10.1016/j.resinv.2021.04.011 Lundberg IE, de Visser M, Werth VP (2018) Classification of myositis. Nat Rev Rheumatol 14:269–278. https://doi.org/10.1038/nrrheum.2018.41 Kontzias A, Barkhodari A, Yao Q (2020) Pericarditis in systemic rheumatologic diseases. Curr Cardiol Rep 22:142. https://doi.org/10.1007/s11886-020-01415-w Bautista-Vargas M, Vivas AJ, Tobón GJ (2020) Minor salivary gland biopsy: Its role in the classification and prognosis of Sjögren’s syndrome. Autoimmun Rev 19:102690. https://doi.org/10.1016/j.autrev.2020.102690 Vlachoyiannopoulos PG, Guialis A, Tzioufas G, Moutsopoulos HM (1996) Predominance of IgM anti-U1RNP antibodies in patients with systemic lupus erythematosus. Br J Rheumatol 35:534–541. https://doi.org/10.1093/rheumatology/35.6.534 Abdelgalil-Ali-Ahmed S, Adam Essa ME, Ahmed AF, Elagib EM, Ahmed Eltahir NI, Awadallah H, Hassan A, Khair ASM, Ebad MAB (2021) Incidence and clinical pattern of mixed connective tissue disease in Sudanese patients at Omdurman Military Hospital: hospital-based study. Open Access Rheumatol Res Rev. 13:333–341. https://doi.org/10.2147/OARRR.S335206 Bodolay E, Szekanecz Z, Dévényi K, Galuska L, Csípo I, Vègh J, Garai I, Szegedi G (2005) Evaluation of interstitial lung disease in mixed connective tissue disease (MCTD). Rheumatol Oxf Engl 44:656–661. https://doi.org/10.1093/rheumatology/keh575 Khanna D, Gladue H, Channick R, Chung L, Distler O, Furst DE, Hachulla E, Humbert M, Langleben D, Mathai SC, Saggar R, Visovatti S, Altorok N, Townsend W, FitzGerald J, McLaughlin VV (2013) Scleroderma Foundation and Pulmonary Hypertension Association, recommendations for screening and detection of connective tissue disease-associated pulmonary arterial hypertension. Arthritis Rheum 65:3194–3201. https://doi.org/10.1002/art.38172 Alpert MA, Goldberg SH, Singsen BH, Durham JB, Sharp GC, Ahmad M, Madigan NP, Hurst DP, Sullivan WD (1983) Cardiovascular manifestations of mixed connective tissue disease in adults. Circulation 68:1182–1193. https://doi.org/10.1161/01.cir.68.6.1182 Szodoray P, Hajas A, Kardos L, Dezso B, Soos G, Zold E, Vegh J, Csipo I, Nakken B, Zeher M, Szegedi G, Bodolay E (2012) Distinct phenotypes in mixed connective tissue disease: subgroups and survival. Lupus 21:1412–1422. https://doi.org/10.1177/0961203312456751 Carpintero MF, Martinez L, Fernandez I, Romero ACG, Mejia C, Zang YJ, Hoffman RW, Greidinger EL (2015) Diagnosis and risk stratification in patients with anti-RNP autoimmunity. Lupus 24:1057–1066. https://doi.org/10.1177/0961203315575586 Mesa A, Somarelli JA, Wu W, Martinez L, Blom MB, Greidinger EL, Herrera RJ (2013) Differential immunoglobulin class-mediated responses to components of the U1 small nuclear ribonucleoprotein particle in systemic lupus erythematosus and mixed connective tissue disease. Lupus 22:1371–1381. https://doi.org/10.1177/0961203313508444 Somarelli J, Mesa A, Rodriguez R, Avellan R, Martinez L, Zang Y, Greidinger E, Herrera R (2011) Epitope mapping of the U1 small nuclear ribonucleoprotein particle in patients with systemic lupus erythematosus and mixed connective tissue disease. Lupus 20:274–289. https://doi.org/10.1177/0961203310387180 Chebbi PP, Goel R, Ramya J, Gowri M, Herrick A, Danda D (2021) Nailfold capillaroscopy changes associated with anti-RNP antibodies in systemic lupus erythematosus. Rheumatol Int. https://doi.org/10.1007/s00296-021-04894-4